Investigation of the Effects of Abatacept on Rheumatoid Arthritis: Analysis of Efficacy on Arthritis and Atherosclerosis
Not Applicable
Recruiting
- Conditions
- Rheumatoid Arthritis
- Registration Number
- JPRN-UMIN000014913
- Lead Sponsor
- Department of Internal Medicine, Toho University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 280
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients who correspond to the contraindications of abatacept 2)Patients with active infection and malignant tumor 3)Patients aged less than 20 years 4)Pregnant and lactating women and women who are willing to become pregnant 5)Patients from whom consent for participation in the study cannot be obtained 6)Patients who are judged inappropriate for participation in the study by the investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method EULAR good response rate at 6 months will be compared between the ABT and csDMARD groups in young patients and in elderly patients. Changes in intima-media thickness by carotid duplex at 3 years will be compared between the ABT and csDMARD groups in young patients and in elderly patients.
- Secondary Outcome Measures
Name Time Method